ReviewPharmacoEconomics2012

Dabigatran etexilate: a pharmacoeconomic review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Kate McKeagePubMed ↗Publisher ↗

No numbers read from the abstract.